Clinical studies recruiting near Shelby

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphospha
Phase 2 · St. Clair Nephrology Research · R1 Therapeutics · NCT06712654 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Carolina Research Center, Inc · Kallyope Inc. · NCT07674654 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Atrium Health Cleveland/LCI-Cleveland · NRG Oncology · NCT05624996 Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Phase 2 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06989359 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · St. Clair Nephrology Research, LLC - Shelby Township · Boehringer Ingelheim · NCT07355296 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Tennessee Oncology, PLLC - Shelbyville · Pfizer · NCT07144280 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · St. Clair Nephrology Research, LLC · Boehringer Ingelheim · NCT06531824 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · Atrium Health Cleveland/LCI-Cleveland · NRG Oncology · NCT06532279 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Cardinal Clinical Research, LLC - Shelby · Boehringer Ingelheim · NCT07220083 A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
Phase 2 · Shelby Clinical Research · Crystalys Therapeutics · NCT07535034 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Henry Ford Macomb Health Center - Shelby Township · National Cancer Institute (NCI) · NCT04269902 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Atrium Health Cleveland/LCI-Cleveland · NRG Oncology · NCT06748222 A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Phase 3 · Shelby Clinical Research, LLC - North Carolina · Crystalys Therapeutics · NCT07089888 Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIR
Phase 3 · Novartis Pharmaceuticals · NCT06133972 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Local Institution - 1252 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Atrium Health Cleveland/LCI-Cleveland · NRG Oncology · NCT04852887 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 A Study of Dotinurad Versus Allopurinol in Participants With Gout
Phase 3 · Shelby Clinical Research, LLC - North Carolina · Crystalys Therapeutics · NCT07089875 To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
Phase 2 · Carolina Research Center, Inc. · Expedition Therapeutics, Inc · NCT07684820 A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Phase 2 · Boehringer Ingelheim · NCT07409181 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Atrium Health Cleveland/LCI-Cleveland · National Cancer Institute (NCI) · NCT05987241 A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · Carolina Research Center · Hoffmann-La Roche · NCT05878769 An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants W
Phase 2 · Core, Inc. · Dompé Farmaceutici S.p.A · NCT07503886 Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head
Phase 2 · Henry Ford Macomb Health Center - Shelby Township · ECOG-ACRIN Cancer Research Group · NCT02734537 A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirze
Phase 2 · Shelby Clinical Research · Eli Lilly and Company · NCT06897475 Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabo
Phase 2 · Henry Ford Macomb Health Center - Shelby Township · National Cancer Institute (NCI) · NCT03866382 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Henry Ford Macomb Health Center - Shelby Township · National Cancer Institute (NCI) · NCT04267848 Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Phase 3 · Henry Ford Macomb Health Center - Shelby Township · ECOG-ACRIN Cancer Research Group · NCT03937635 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Henry Ford Macomb Health Center - Shelby Township · SWOG Cancer Research Network · NCT03851445 A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Phase 2 · Research Site · Maze Therapeutics · NCT06830629

Look up another city

Look up another condition